Effects of hydroxyflutamide on rats treated with a superovulatory dose of pregnant mare serum gonadotropin.

The research focuses on understanding the effects of the antiandrogen drug hydroxyflutamide on ovarian steroid production in rats treated with a hormone to induce superovulation. Key findings include a reduction in the percentage of abnormal oocytes, a decrease in certain steroid levels, and evidence that these effects might be influenced by hydroxyflutamide’s disruption of androgen binding in the ovary.

Experiments and Methodology

The research was conducted across two separate experiments. Both experiments made use of immature female rats that were treated with pregnant mare serum gonadotropin (PMSG), a hormone used to stimulate ovarian follicle development.

• For the first experiment, the rats were given either a 5 mg dose of hydroxyflutamide or a placebo after treatment with PMSG. The team studied the oocytes (unfertilized egg cells) recovered from the rats, and analyzed the steroid levels in the rats’ serum.
• The second experiment involved incubating ovaries that were stimulated with PMSG with or without both testosterone and hydroxyflutamide present. The aim was to study the changes in [4-14C]pregnenolone metabolism, a precursor molecule to major steroid production.

Results and Analysis

In the first experiment, the hydroxyflutamide treatment showed a prominent reduction in the occurrence of degenerate oocytes (abnormal egg cells) as compared to the control group. Furthermore, different steroid hormone levels like testosterone, androstenedione, and their aromatized product 17 beta-estradiol significantly decreased in the treated rats. However, the level of nonaromatizable androgen (an androgen resistant to changes into other hormones) 5 alpha-dihydrotestosterone remained unaffected.

The results of the second experiment indicated that in the presence of hydroxyflutamide, there was a significant decrease in the conversion of pregnenolone to progesterone and androstenedione in ovaries stimulated with PMSG. Meanwhile, production of 17 beta-estradiol increased significantly. Interestingly, the presence of testosterone reversed the effect of hydroxyflutamide on pregnenolone metabolism, highlighting a complex interaction between these substances.

Conclusion

The research concludes that hydroxyflutamide impacts the production of oocytes and modifies ovarian steroidogenesis in superovulating rats. Moreover, this effect might be driven by the ability of hydroxyflutamide to inhibit androgen binding in the ovary. These findings extend previous knowledge about hydroxyflutamide and may have implications for understanding hormonal interactions and the impact of antiandrogens on fertility.